US Stock MarketDetailed Quotes

aTyr Pharma (ATYR)

Watchlist
  • 0.7951
  • 0.00000.00%
Close Apr 7 16:00 ET
  • 0.8301
  • +0.0350+4.40%
Pre 08:37 ET
77.96MMarket Cap-0.99P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

aTyr Pharma (ATYR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-19.15%190K
0
190K
0
0
-33.43%235K
0
0
0
235K
Operating revenue
-19.15%190K
--0
--190K
--0
--0
-33.43%235K
--0
--0
--0
--235K
Cost of revenue
Gross profit
Operating expense
14.19%77.82M
-6.47%14.8M
48.46%26.94M
17.31%20.31M
-6.51%15.77M
23.30%68.15M
-0.87%15.82M
39.91%18.14M
27.71%17.32M
31.94%16.87M
Selling and administrative expenses
27.73%17.6M
8.71%3.91M
44.03%4.81M
47.49%4.93M
12.89%3.96M
6.15%13.78M
12.11%3.59M
25.93%3.34M
-10.11%3.34M
2.90%3.51M
-General and administrative expense
27.73%17.6M
8.71%3.91M
44.03%4.81M
47.49%4.93M
12.89%3.96M
6.15%13.78M
12.11%3.59M
25.93%3.34M
-10.11%3.34M
2.90%3.51M
Research and development costs
10.75%60.22M
-10.93%10.89M
49.46%22.13M
10.10%15.38M
-11.60%11.81M
28.56%54.37M
-4.13%12.23M
43.49%14.81M
42.00%13.97M
42.49%13.36M
Operating profit
-14.30%-77.63M
6.47%-14.8M
-47.41%-26.75M
-17.31%-20.31M
5.19%-15.77M
-23.66%-67.91M
0.87%-15.82M
-43.82%-18.14M
-27.71%-17.32M
-30.10%-16.64M
Net non-operating interest income expense
Other net income (expense)
-9.97%3.5M
-2.35%832K
13.27%999K
-22.60%781K
-22.37%892K
-13.93%3.89M
-28.88%852K
-30.71%882K
-17.02%1.01M
37.60%1.15M
Other non- operating income (expenses)
-9.97%3.5M
-2.35%832K
13.27%999K
-22.60%781K
-22.37%892K
-13.93%3.89M
-28.88%852K
-30.71%882K
-17.02%1.01M
37.60%1.15M
Income before tax
-15.78%-74.12M
6.71%-13.96M
-49.16%-25.75M
-19.78%-19.53M
3.91%-14.88M
-27.04%-64.02M
-1.40%-14.97M
-52.19%-17.26M
-32.12%-16.31M
-29.58%-15.49M
Income tax
Net income
-15.78%-74.12M
6.71%-13.96M
-49.16%-25.75M
-19.78%-19.53M
3.91%-14.88M
-27.04%-64.02M
-1.40%-14.97M
-52.19%-17.26M
-32.12%-16.31M
-29.58%-15.49M
Net income continuous Operations
-15.78%-74.12M
6.71%-13.96M
-49.16%-25.75M
-19.78%-19.53M
3.91%-14.88M
-27.04%-64.02M
-1.40%-14.97M
-52.19%-17.26M
-32.12%-16.31M
-29.58%-15.49M
Minority interest income
-600.00%-5K
0.00%-1K
0.00%-2K
-1K
-125.00%-1K
112.50%1K
0.00%-1K
0.00%-2K
0
500.00%4K
Net income attributable to the parent company
-15.77%-74.12M
6.71%-13.96M
-49.16%-25.74M
-19.78%-19.53M
3.94%-14.88M
-27.06%-64.02M
-1.40%-14.97M
-52.20%-17.26M
-32.16%-16.31M
-29.62%-15.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-15.77%-74.12M
6.71%-13.96M
-49.16%-25.74M
-19.78%-19.53M
3.94%-14.88M
-27.06%-64.02M
-1.40%-14.97M
-52.20%-17.26M
-32.16%-16.31M
-29.62%-15.49M
Basic earnings per share
6.98%-0.8
22.22%-0.14
-13.04%-0.26
4.35%-0.22
26.09%-0.17
8.51%-0.86
28.00%-0.18
-15.00%-0.23
-4.55%-0.23
20.69%-0.23
Diluted earnings per share
6.98%-0.8
22.22%-0.14
-13.04%-0.26
4.35%-0.22
26.09%-0.17
8.51%-0.86
28.00%-0.18
-15.00%-0.23
-4.55%-0.23
20.69%-0.23
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -19.15%190K0190K00-33.43%235K000235K
Operating revenue -19.15%190K--0--190K--0--0-33.43%235K--0--0--0--235K
Cost of revenue
Gross profit
Operating expense 14.19%77.82M-6.47%14.8M48.46%26.94M17.31%20.31M-6.51%15.77M23.30%68.15M-0.87%15.82M39.91%18.14M27.71%17.32M31.94%16.87M
Selling and administrative expenses 27.73%17.6M8.71%3.91M44.03%4.81M47.49%4.93M12.89%3.96M6.15%13.78M12.11%3.59M25.93%3.34M-10.11%3.34M2.90%3.51M
-General and administrative expense 27.73%17.6M8.71%3.91M44.03%4.81M47.49%4.93M12.89%3.96M6.15%13.78M12.11%3.59M25.93%3.34M-10.11%3.34M2.90%3.51M
Research and development costs 10.75%60.22M-10.93%10.89M49.46%22.13M10.10%15.38M-11.60%11.81M28.56%54.37M-4.13%12.23M43.49%14.81M42.00%13.97M42.49%13.36M
Operating profit -14.30%-77.63M6.47%-14.8M-47.41%-26.75M-17.31%-20.31M5.19%-15.77M-23.66%-67.91M0.87%-15.82M-43.82%-18.14M-27.71%-17.32M-30.10%-16.64M
Net non-operating interest income expense
Other net income (expense) -9.97%3.5M-2.35%832K13.27%999K-22.60%781K-22.37%892K-13.93%3.89M-28.88%852K-30.71%882K-17.02%1.01M37.60%1.15M
Other non- operating income (expenses) -9.97%3.5M-2.35%832K13.27%999K-22.60%781K-22.37%892K-13.93%3.89M-28.88%852K-30.71%882K-17.02%1.01M37.60%1.15M
Income before tax -15.78%-74.12M6.71%-13.96M-49.16%-25.75M-19.78%-19.53M3.91%-14.88M-27.04%-64.02M-1.40%-14.97M-52.19%-17.26M-32.12%-16.31M-29.58%-15.49M
Income tax
Net income -15.78%-74.12M6.71%-13.96M-49.16%-25.75M-19.78%-19.53M3.91%-14.88M-27.04%-64.02M-1.40%-14.97M-52.19%-17.26M-32.12%-16.31M-29.58%-15.49M
Net income continuous Operations -15.78%-74.12M6.71%-13.96M-49.16%-25.75M-19.78%-19.53M3.91%-14.88M-27.04%-64.02M-1.40%-14.97M-52.19%-17.26M-32.12%-16.31M-29.58%-15.49M
Minority interest income -600.00%-5K0.00%-1K0.00%-2K-1K-125.00%-1K112.50%1K0.00%-1K0.00%-2K0500.00%4K
Net income attributable to the parent company -15.77%-74.12M6.71%-13.96M-49.16%-25.74M-19.78%-19.53M3.94%-14.88M-27.06%-64.02M-1.40%-14.97M-52.20%-17.26M-32.16%-16.31M-29.62%-15.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -15.77%-74.12M6.71%-13.96M-49.16%-25.74M-19.78%-19.53M3.94%-14.88M-27.06%-64.02M-1.40%-14.97M-52.20%-17.26M-32.16%-16.31M-29.62%-15.49M
Basic earnings per share 6.98%-0.822.22%-0.14-13.04%-0.264.35%-0.2226.09%-0.178.51%-0.8628.00%-0.18-15.00%-0.23-4.55%-0.2320.69%-0.23
Diluted earnings per share 6.98%-0.822.22%-0.14-13.04%-0.264.35%-0.2226.09%-0.178.51%-0.8628.00%-0.18-15.00%-0.23-4.55%-0.2320.69%-0.23
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +32.35%
Sample Name
Sample Code
 +25.61%
Sample Name
Sample Code
 +25.28%
4
United States Gasoline Fund Lp
UGA
+24.64%
5
ProShares Ultra Energy
DIG
+14.83%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.65%
Sample Name
Sample Code
 +14.21%
Sample Name
Sample Code
 +11.43%
4
Taiwan Semiconductor
TSM
+9.11%
5
United Microelectronics
UMC
+8.13%
View More
Middle East conflict spreads to the stock market! How should investors respond?
A major turning point has emerged in the US-Iran situation! Trump announced a two-week suspension of military action against Iran, and both Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -